Physician profile
Sharon E Selinger
NPI 1447337415
$4,624.98
in general payments reported to CMS, 2019-2025
45 companies · $1,094 in 2025
The $1,094 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $591 · 2020: $898 · 2021: $211 · 2022: $570 · 2023: $485 · 2024: $776 · 2025: $1,094.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,338 · Education: $16.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,337.64 |
| Education | $16.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Minimed, INC. | $865.28 | 2019-2020 | |
| Novo Nordisk INC | $861.44 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $354.10 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Amgen INC. | $338.34 | 2019-2025 | Evenity, Tepezza, Prolia |
| Abbvie INC. | $234.94 | 2019-2025 | |
| Amneal Pharmaceuticals LLC | $168.69 | 2019-2025 | Unithroid |
| Sanofi-Aventis U.S. LLC | $136.52 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $135.93 | 2019-2025 | Jardiance |
| Dexcom, INC. | $124.96 | 2021-2025 | Dexcom G6 Transmitter |
| Medtronic, INC. | $103.51 | 2021-2025 | Minimed 780g |
| Insulet Corporation | $88.79 | 2023-2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $81.35 | 2021-2025 | Strensiq |
| Pfizer INC. | $79.98 | 2019-2025 | |
| Ibsa Pharma INC. | $72.38 | 2019-2025 | Flector, Licart, Tirosint |
| Radius Health, INC. | $71.88 | 2019-2025 | Tymlos |
Show all 45 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Selinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.